Jeil Pharmaceutical Co Ltd Working Capital to Net Assets Ratio
Jeil Pharmaceutical Co Ltd working capital to net assets ratio. Jeil Pharmaceutical Co Ltd (271980) has a Working Capital to Net Assets ratio of 32.3% as of June 2026. Working capital of ₩81.81 Billion (current assets of ₩330.25 Billion minus current liabilities of ₩248.44 Billion) is measured against net assets of ₩253.26 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check Jeil Pharmaceutical Co Ltd (271980) tangible equity ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Jeil Pharmaceutical Co Ltd (2017–2025)
Working capital to net assets ratio of Jeil Pharmaceutical Co Ltd from 2017 to 2025. This chart shows how Jeil Pharmaceutical Co Ltd's Working Capital to Net Assets ratio has evolved across 9 annual periods from 2017 to 2025. As of June 2026, the ratio stands at 32.3%, reflecting working capital of ₩81.81 Billion against net assets of ₩253.26 Billion KRW. See Jeil Pharmaceutical Co Ltd (271980) liquidity interval to measure how many days the company can operate on defensive assets alone.
Jeil Pharmaceutical Co Ltd Working Capital to Net Assets Ratio by Year (2017–2025)
Jeil Pharmaceutical Co Ltd working capital to net assets ratio by year from 2017 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Jeil Pharmaceutical Co Ltd from 2017 to 2025, covering 9 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see 271980 asset base.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 27.6% | ₩69.17 Billion | ₩251.03 Billion | ₩311.62 Billion | ₩242.45 Billion | ▲ +4.1 pp |
| 2024 | 23.4% | ₩51.35 Billion | ₩219.32 Billion | ₩343.04 Billion | ₩291.69 Billion | ▲ +24.1 pp |
| 2023 | -0.7% | ₩-1.12 Billion | ₩157.03 Billion | ₩317.05 Billion | ₩318.17 Billion | ▼ -15.5 pp |
| 2022 | 14.8% | ₩22.98 Billion | ₩155.60 Billion | ₩291.64 Billion | ₩268.66 Billion | ▼ -22.7 pp |
| 2021 | 37.5% | ₩62.73 Billion | ₩167.35 Billion | ₩284.67 Billion | ₩221.94 Billion | ▲ +3.0 pp |
| 2020 | 34.5% | ₩59.45 Billion | ₩172.48 Billion | ₩277.51 Billion | ₩218.06 Billion | ▲ +1.8 pp |
| 2019 | 32.7% | ₩55.61 Billion | ₩170.04 Billion | ₩264.13 Billion | ₩208.52 Billion | ▼ -9.9 pp |
| 2018 | 42.6% | ₩78.80 Billion | ₩184.93 Billion | ₩273.36 Billion | ₩194.56 Billion | ▼ -9.2 pp |
| 2017 | 51.8% | ₩92.15 Billion | ₩177.99 Billion | ₩298.60 Billion | ₩206.46 Billion | — |